Glucagon Prescribing Not in Full Alignment With ADA Guidelines | ADA 2025
Drug Topics
JUNE 25, 2025
Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurance coverage. on long-acting insulin only receiving a glucagon fill.
Let's personalize your content